Wstęp
Ta strona zawiera kompleksową analizę znanej historii wykorzystywania informacji poufnych w firmie C Frank Bennett. Insiderzy to członkowie kadry kierowniczej, dyrektorzy lub znaczący inwestorzy w spółce. Dokonywanie transakcji w ich firmach w oparciu o określone, niepubliczne informacje jest nielegalne. Nie oznacza to, że dokonywanie jakichkolwiek transakcji we własnych firmach jest nielegalne. Muszą jednak zgłaszać wszystkie transakcje do SEC za pośrednictwem formularza 4. Pomimo tych ograniczeń badania akademickie sugerują, że insiderzy – ogólnie rzecz biorąc – mają tendencję do osiągania lepszych wyników na rynku w swoich własnych firmach.
Średnia rentowność handlu
Średnia rentowność handlu to średni zwrot ze wszystkich zakupów na otwartym rynku dokonanych przez osobę mającą dostęp do informacji poufnych w ciągu ostatnich trzech lat. Aby to obliczyć, badamy każdy nieplanowany zakup na otwartym rynku dokonany przez insidera, z wyłączeniem wszystkich transakcji oznaczonych jako część planu handlowego 10b5-1. Następnie obliczamy średnią wydajność tych transakcji w ciągu 3, 6 i 12 miesięcy, uśredniając każdy z tych okresów, aby wygenerować ostateczny wskaźnik wydajności dla każdej transakcji. Na koniec uśredniamy wszystkie wskaźniki wydajności, aby obliczyć wskaźnik wydajności dla insidera. Na tej liście znajdują się wyłącznie insiderzy, którzy dokonali co najmniej trzech transakcji w ciągu ostatnich dwóch lat.
Jeśli rentowność handlu insiderów jest oznaczona notką„nie dotyczy”, oznacza to, że insider albo nie dokonał żadnych zakupów na otwartym rynku w ciągu ostatnich trzech lat, albo transakcje, których dokonał, są zbyt nowe, aby obliczyć wiarygodny wskaźnik wydajności.
Częstotliwość aktualizacji: codziennie
Spółki posiadające zgłoszone stanowiska osób mających dostęp do poufnych informacji
Z dokumentów SEC wynika, że C Frank Bennett zgłosił udziały lub transakcje w następujących spółkach:
| Papier wartościowy | Nazwa | Najnowsze raporty dotyczące udziałów |
|---|---|---|
| US:IONS / Ionis Pharmaceuticals, Inc. | EVP, Chief Scientific Officer | 80 554 |
Jak interpretować wykresy
Poniższe wykresy przedstawiają notowania akcji papierów wartościowych po każdej niezaplanowanej transakcji na otwartym rynku dokonanej przez C Frank Bennett. Nieplanowane transakcje to transakcje, które nie zostały dokonane w ramach planu handlowego 10b5-1. Notowania akcji przedstawiono na wykresie jako skumulowaną procentową zmianę ceny akcji. Na przykład, jeśli 1 stycznia 2019 r. dokonano transakcji poufnej, wykres pokaże dzienną procentową zmianę papieru wartościowego do dnia dzisiejszego. Jeżeli cena akcji wzrosłaby w tym czasie z 10 do 15 dolarów, skumulowana procentowa zmiana ceny akcji wyniosłaby 50%. Zmiana ceny z 10$ na 20$ będzie wynosić 100%, a zmiana ceny z 10$ na 5$ będzie wynosić -50%.
Ostatecznie staramy się określić, jak blisko transakcje insiderów korelują z nadmiernymi zwrotami (dodatnimi lub ujemnymi) z ceny akcji, aby sprawdzić, czy insider dostosowuje swoje transakcje w taki sposób, aby czerpać korzyści z informacji poufnych. Rozważmy sytuację, w której zrobił to ktoś z wewnątrz. W tej sytuacji oczekiwalibyśmy albo (a) dodatnich zwrotów po zakupach, albo (b) ujemnych zwrotów po sprzedaży. W przypadku (a) wykres ZAKUPU pokazywałby serię krzywych nachylonych w górę, wskazujących dodatnie zwroty po każdej transakcji zakupu. W przypadku (b) wykres SPRZEDAŻ pokazywałby serię krzywych o nachyleniu w dół, wskazujących ujemne zwroty po każdej transakcji sprzedaży.
Samo to jednak nie wystarczy, aby wyciągnąć wnioski. Gdyby np. cena akcji spółki przez wiele lat rosła niecyklicznie, to spodziewalibyśmy się, że wszystkie wykresy po zakupie będą wykazywały tendencję wzrostową. Podobnie niecykliczne spadki na przestrzeni wielu lat spowodowałyby spadek linii na wykresie po transakcjach. Żaden z tych wykresów nie sugeruje wykorzystywania informacji poufnych.
Najsilniejszym wskaźnikiem byłaby sytuacja, gdy cena akcji miała charakter wyjątkowo cykliczny, a na wykresie KUPNO występowały zarówno pozytywne sygnały na wykresie KUPNA, jak i negatywne na wykresie SPRZEDAŻY. Sytuacja ta wysoce sugerowałaby osobę mającą dostęp do informacji poufnych, która wykorzystywała transakcje w celu uzyskania korzyści finansowej.
Zakupy insidera IONS / Ionis Pharmaceuticals, Inc. – krótkoterminowa analiza zysków
W tej części analizujemy rentowność każdego nieplanowanego zakupu od poufnych informacji na otwartym rynku dokonanego w IONS / Ionis Pharmaceuticals, Inc.. Analiza ta pomaga zrozumieć, czy insider konsekwentnie generuje nietypowe zyski i czy warto ją śledzić. Analiza ta obejmuje okres jednego roku po każdej transakcji, a wyniki mają charakter teoretyczny .
Poniższa tabela przedstawia najnowsze zakupy na otwartym rynku, które nie były częścią planu handlu automatycznego.
| Data transakcji | Ticker | Insider | Zgłoszone Akcje |
Zgłoszona Cena |
Skorygowane Akcje |
Skorygowana Cena |
Podstawa kalkulacji kosztów | Dni do maks |
Cena maks |
Maks Zysk ($) |
Maksymalny zwrot (%) |
|---|---|---|---|---|---|---|---|
| Nie znane są żadne nieplanowane transakcje na otwarttm rynku dla tej kombinacji insidera i papieru wartościowego |
Cena skorygowana to cena skorygowana o podział. Akcje skorygowane to akcje skorygowane o podział.
Sprzedaż insidera IONS / Ionis Pharmaceuticals, Inc. — analiza strat krótkoterminowych
W tej sekcji analizujemy możliwość uniknięcia krótkoterminowych strat w wyniku każdej nieplanowanej sprzedaży poufnych informacji na otwartym rynku dokonanej w IONS / Ionis Pharmaceuticals, Inc.. Konsekwentny wzorzec unikania strat może sugerować, że przyszłe transakcje sprzedaży mogą przewidywać spadki cen. Analiza ta obejmuje okres jednego roku po każdej transakcji, a wyniki mają charakter teoretyczny .
Poniższa tabela przedstawia najnowsze sprzedaże na otwartym rynku, które nie były częścią planu handlu automatycznego.
Cena skorygowana to cena skorygowana o podział. Akcje skorygowane to akcje skorygowane o podział.
Historia handlu insiderów
Ta tabela przedstawia pełną listę transakcji insiderów dokonanych przez firmę C Frank Bennett ujawnioną Komisji Papierów Wartościowych (SEC).
| Data pliku | Data trans | Formularz | Ticker | Bezpieczeństwo | Kod | Akcje | Pozostałe akcje | Zmiana procent |
Cena udziału |
Wartość trans |
Pozostała Wartość |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-05 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -802 | 80 554 | -0,99 | 80,76 | -64 771 | 6 505 702 |
| 2026-03-05 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -12 687 | 81 356 | -13,49 | 79,88 | -1 013 410 | 6 498 538 |
| 2026-03-05 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -71 600 | 94 043 | -43,23 | 79,10 | -5 663 488 | 7 438 707 |
| 2026-03-05 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 48 626 | 165 643 | 41,55 | 60,89 | 2 960 837 | 10 086 002 | |
| 2026-03-05 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 16 463 | 117 017 | 16,37 | 32,60 | 536 694 | 3 814 754 | |
| 2026-03-03 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
J - Other | 261 | 100 554 | 0,26 | 48,87 | 12 754 | 4 913 722 | |
| 2026-02-13 |
|
4/A | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
J - Other | 0 | 100 293 | 0,00 | ||||
| 2026-02-04 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | -16 463 | 80 293 | -17,01 | 83,03 | -1 366 897 | 6 666 599 | |
| 2026-02-04 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 16 463 | 96 756 | 20,50 | 32,60 | 536 694 | 3 154 246 | |
| 2026-02-04 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | -48 626 | 80 293 | -37,72 | 83,03 | -4 037 339 | 6 666 599 | |
| 2026-02-04 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 48 626 | 128 919 | 60,56 | 60,89 | 2 960 837 | 7 849 878 | |
| 2026-02-04 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | -20 000 | 80 293 | -19,94 | 82,60 | -1 651 980 | 6 632 122 | |
| 2026-02-02 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | -5 885 | 100 293 | -5,54 | 82,95 | -488 141 | 8 318 963 | |
| 2026-02-02 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
A - Award | 11 421 | 106 178 | 12,05 | ||||
| 2026-01-20 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | -8 977 | 94 757 | -8,65 | 75,15 | -674 622 | 7 120 989 | |
| 2026-01-20 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 21 055 | 103 734 | 25,47 | ||||
| 2025-09-09 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -6 000 | 82 679 | -6,77 | 59,60 | -357 581 | 4 927 404 |
| 2025-09-04 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | -12 891 | 88 679 | -12,69 | 61,50 | -792 796 | 5 453 758 |
| 2025-09-04 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -33 909 | 101 570 | -25,03 | 60,62 | -2 055 564 | 6 157 173 |
| 2025-09-04 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 46 800 | 135 479 | 52,77 | 53,77 | 2 516 436 | 7 284 706 | |
| 2025-09-04 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -5 000 | 88 679 | -5,34 | 49,14 | -245 700 | 4 357 686 |
| 2025-09-03 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
J - Other | 213 | 93 679 | 0,23 | 27,71 | 5 902 | 2 595 845 | |
| 2025-08-20 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -10 000 | 93 466 | -9,67 | 43,98 | -439 776 | 4 110 410 |
| 2025-08-20 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 10 000 | 103 466 | 10,70 | 32,60 | 326 000 | 3 372 992 | |
| 2025-03-04 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
J - Other | 320 | 93 466 | 0,34 | 28,21 | 9 028 | 2 636 816 | |
| 2025-02-03 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | -1 327 | 93 146 | -1,40 | 32,46 | -43 079 | 3 023 854 | |
| 2025-02-03 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
A - Award | 3 607 | 94 473 | 3,97 | ||||
| 2025-01-17 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | -6 752 | 90 866 | -6,92 | 32,90 | -222 114 | 2 989 128 | |
| 2025-01-17 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 18 011 | 97 618 | 22,62 | ||||
| 2024-09-04 |
|
4/A | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | -1 885 | 79 047 | -2,33 | 49,52 | -93 337 | 3 914 060 | |
| 2024-09-04 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
J - Other | 177 | 79 607 | 0,22 | 38,64 | 6 839 | 3 076 094 | |
| 2024-03-04 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
J - Other | 383 | 79 462 | 0,48 | 34,42 | 13 185 | 2 735 479 | |
| 2024-02-02 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | -1 853 | 79 079 | -2,29 | 49,52 | -91 752 | 3 915 644 | |
| 2024-02-02 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
A - Award | 3 609 | 80 932 | 4,67 | ||||
| 2024-01-18 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | -6 745 | 77 323 | -8,02 | 50,42 | -340 063 | 3 898 394 | |
| 2024-01-18 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 18 314 | 84 068 | 27,85 | ||||
| 2023-12-22 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | -16 113 | 65 754 | -19,68 | 49,29 | -794 211 | 3 241 021 | |
| 2023-12-22 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 16 113 | 81 867 | 24,50 | 47,34 | 762 789 | 3 875 584 | |
| 2023-12-22 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | -6 500 | 65 754 | -9,00 | 49,64 | -322 643 | 3 263 858 | |
| 2023-12-22 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 6 500 | 72 254 | 9,89 | 47,34 | 307 710 | 3 420 504 | |
| 2023-12-18 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | -8 610 | 65 754 | -11,58 | 50,19 | -432 110 | 3 299 996 | |
| 2023-12-18 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 8 610 | 74 364 | 13,09 | 47,34 | 407 597 | 3 520 392 | |
| 2023-12-18 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | -14 002 | 65 754 | -17,56 | 49,21 | -689 085 | 3 235 971 | |
| 2023-12-18 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 14 002 | 79 756 | 21,29 | 47,34 | 662 855 | 3 775 649 | |
| 2023-09-29 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -4 460 | 65 754 | -6,35 | 46,50 | -207 390 | 3 057 561 |
| 2023-09-05 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
J - Other | 180 | 70 214 | 0,26 | 30,56 | 5 500 | 2 145 564 | |
| 2023-03-02 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
J - Other | 383 | 70 034 | 0,55 | 30,52 | 11 687 | 2 137 088 | |
| 2023-02-07 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | -1 813 | 69 651 | -2,54 | 40,57 | -73 560 | 2 826 006 | |
| 2023-02-07 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
A - Award | 3 609 | 71 464 | 5,32 | ||||
| 2023-01-19 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | -6 978 | 67 855 | -9,32 | 38,89 | -271 356 | 2 638 705 | |
| 2023-01-19 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 19 417 | 74 833 | 35,04 | ||||
| 2022-09-01 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
J - Other | 183 | 55 416 | 0,33 | 28,97 | 5 301 | 1 605 291 | |
| 2022-03-02 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
J - Other | 346 | 55 233 | 0,63 | 28,37 | 9 817 | 1 567 126 | |
| 2022-01-20 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Restricted Stock Unit |
M - Exercise | -18 842 | 24 444 | -43,53 | ||||
| 2022-01-20 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
F - Taxes | -6 726 | 54 887 | -10,92 | 30,12 | -202 587 | 1 653 196 | |
| 2022-01-20 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 18 842 | 61 613 | 44,05 | ||||
| 2022-01-19 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Restricted Stock Unit |
A - Award | 14 435 | 43 286 | 50,03 | ||||
| 2022-01-19 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Performance Restricted Stock Units |
A - Award | 10 826 | 10 826 | |||||
| 2022-01-05 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
A - Award | 28 869 | 28 869 | |||||
| 2021-09-02 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
J - Other | 151 | 42 771 | 0,35 | 33,80 | 5 103 | 1 445 489 | |
| 2021-03-02 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
J - Other | 112 | 42 620 | 0,26 | 44,54 | 4 988 | 1 898 295 | |
| 2021-01-20 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | -15 520 | 29 641 | -34,37 | ||||
| 2021-01-20 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Restricted Stock Units |
A - Award | 20 822 | 20 822 | |||||
| 2021-01-20 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
F - Taxes | -5 488 | 42 508 | -11,43 | 61,28 | -336 305 | 2 604 890 | |
| 2021-01-20 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 15 520 | 47 996 | 47,79 | ||||
| 2021-01-06 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
A - Award | 46 850 | 46 850 | |||||
| 2020-12-08 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | -7 947 | 0 | -100,00 | ||||
| 2020-12-08 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -7 947 | 32 476 | -19,66 | 51,04 | -405 615 | 1 657 575 |
| 2020-12-08 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 7 947 | 40 423 | 24,47 | 39,87 | 316 847 | 1 611 665 |
| 2020-12-04 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | -7 053 | 7 947 | -47,02 | ||||
| 2020-12-04 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -7 053 | 32 476 | -17,84 | 51,32 | -361 960 | 1 666 668 |
| 2020-12-04 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 7 053 | 39 529 | 21,72 | 39,87 | 281 203 | 1 576 021 |
| 2020-11-05 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | -15 000 | 15 000 | -50,00 | ||||
| 2020-11-05 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -15 000 | 32 476 | -31,59 | 46,77 | -701 600 | 1 519 010 |
| 2020-11-05 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 15 000 | 47 476 | 46,19 | 39,87 | 598 050 | 1 892 868 |
| 2020-09-02 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
J - Other | 112 | 32 476 | 0,35 | 44,46 | 4 979 | 1 443 721 | |
| 2020-06-29 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -15 000 | 32 364 | -31,67 | 59,77 | -896 505 | 1 934 299 |
| 2020-06-29 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 15 000 | 47 364 | 46,35 | 39,87 | 598 050 | 1 888 403 |
| 2020-03-03 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
J - Other | 169 | 32 364 | 0,52 | 43,16 | 7 295 | 1 396 927 | |
| 2020-01-17 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | -11 711 | 23 549 | -33,21 | ||||
| 2020-01-17 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Restricted Stock Units |
A - Award | 21 612 | 21 612 | |||||
| 2020-01-17 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
F - Taxes | -4 162 | 32 195 | -11,45 | 62,06 | -258 294 | 1 998 022 | |
| 2020-01-17 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 11 711 | 36 357 | 47,52 | ||||
| 2020-01-03 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
A - Award | 48 626 | 48 626 | |||||
| 2019-07-02 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
J - Other | 118 | 24 646 | 0,48 | 45,70 | 5 393 | 1 126 433 | |
| 2019-02-05 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | 9 013 | 0 | -100,00 | ||||
| 2019-02-05 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -9 013 | 24 528 | -26,87 | 58,29 | -525 368 | 1 429 737 |
| 2019-02-05 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 9 013 | 33 541 | 36,75 | 14,69 | 132 401 | 492 717 |
| 2019-01-17 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | -7 822 | 14 463 | -35,10 | ||||
| 2019-01-17 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Restricted Stock Units |
A - Award | 20 797 | 20 797 | |||||
| 2019-01-17 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
F - Taxes | -2 818 | 24 400 | -10,35 | 58,26 | -164 177 | 1 421 544 | |
| 2019-01-17 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 7 822 | 27 218 | 40,33 | ||||
| 2019-01-03 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
A - Award | 46 800 | 46 800 | |||||
| 2019-01-03 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
J - Other | 128 | 19 524 | 0,66 | 36,45 | 4 665 | 711 611 | |
| 2018-11-01 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | 12 500 | 9 013 | -358,47 | ||||
| 2018-11-01 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -12 500 | 19 396 | -39,19 | 49,54 | -619 245 | 960 870 |
| 2018-11-01 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 12 500 | 31 896 | 64,45 | 14,69 | 183 625 | 468 552 |
| 2018-08-09 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | 12 487 | 21 513 | 138,34 | ||||
| 2018-08-09 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | 13 | 0 | -100,00 | ||||
| 2018-08-09 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -12 487 | 19 396 | -39,17 | 45,00 | -561 915 | 872 820 |
| 2018-08-09 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 12 487 | 31 883 | 64,38 | 14,69 | 183 434 | 468 361 |
| 2018-08-09 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -13 | 19 396 | -0,07 | 45,00 | -585 | 872 820 |
| 2018-08-09 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 13 | 19 409 | 0,07 | 7,25 | 94 | 140 715 |
| 2018-07-03 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
J - Other | 282 | 19 396 | 1,48 | 35,42 | 9 988 | 686 997 | |
| 2018-05-11 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | 12 500 | 13 | -100,10 | ||||
| 2018-05-11 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -12 500 | 19 114 | -39,54 | 45,00 | -562 500 | 860 130 |
| 2018-05-11 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 12 500 | 31 614 | 65,40 | 7,25 | 90 625 | 229 202 |
| 2018-02-01 |
|
4/A | IONS |
IONIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | 12 500 | 12 513 | 96 153,85 | ||||
| 2018-02-01 |
|
4/A | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -12 500 | 19 114 | -39,54 | 52,50 | -656 260 | 1 003 500 |
| 2018-02-01 |
|
4/A | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 12 500 | 31 614 | 65,40 | 7,25 | 90 625 | 229 202 |
| 2018-01-17 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | -2 696 | 19 114 | -12,36 | 51,76 | -139 545 | 989 341 | |
| 2018-01-17 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | -6 663 | 10 148 | -39,63 | ||||
| 2018-01-17 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Restricted Stock Units |
A - Award | 12 137 | 12 137 | |||||
| 2018-01-17 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 6 663 | 21 810 | 43,99 | ||||
| 2018-01-02 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
A - Award | 54 619 | 54 619 | |||||
| 2018-01-02 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
J - Other | 106 | 15 147 | 0,70 | 42,76 | 4 532 | 647 610 | |
| 2017-10-20 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | -12 250 | 0 | -100,00 | ||||
| 2017-10-20 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -12 250 | 15 041 | -44,89 | 65,00 | -796 250 | 977 665 |
| 2017-10-20 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 12 250 | 27 291 | 81,44 | 10,29 | 126 052 | 280 824 |
| 2017-07-26 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | -10 000 | 12 250 | -44,94 | ||||
| 2017-07-26 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -10 000 | 15 041 | -39,93 | 59,29 | -592 900 | 891 781 |
| 2017-07-26 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 10 000 | 25 041 | 66,48 | 10,29 | 102 900 | 257 672 |
| 2017-07-03 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
J - Other | 253 | 15 041 | 1,71 | 40,66 | 10 286 | 611 499 | |
| 2017-03-06 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | -5 000 | 22 250 | -18,35 | ||||
| 2017-03-06 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -5 000 | 14 788 | -25,27 | 55,00 | -275 000 | 813 340 |
| 2017-03-06 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 5 000 | 19 788 | 33,81 | 10,29 | 51 450 | 203 619 |
| 2017-01-18 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | -623 | 14 788 | -4,04 | 46,29 | -28 839 | 684 537 | |
| 2017-01-18 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | -512 | 13 817 | -3,57 | 46,29 | -23 701 | 639 603 | |
| 2017-01-18 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | -733 | 13 018 | -5,33 | 46,29 | -33 931 | 602 603 | |
| 2017-01-18 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | -553 | 11 876 | -4,45 | 46,29 | -25 598 | 549 740 | |
| 2017-01-18 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | -1 594 | 4 779 | -25,01 | ||||
| 2017-01-18 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | -1 311 | 2 620 | -33,35 | ||||
| 2017-01-18 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | -1 875 | 1 875 | -50,00 | ||||
| 2017-01-18 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | -1 415 | 0 | -100,00 | ||||
| 2017-01-18 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Restricted Stock Units |
A - Award | 7 537 | 7 537 | |||||
| 2017-01-18 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 1 594 | 15 411 | 11,54 | ||||
| 2017-01-18 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 1 311 | 14 329 | 10,07 | ||||
| 2017-01-18 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 1 875 | 13 751 | 15,79 | ||||
| 2017-01-18 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 1 415 | 12 429 | 12,85 | ||||
| 2017-01-04 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
A - Award | 45 225 | 45 225 | |||||
| 2017-01-04 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
J - Other | 211 | 11 014 | 1,95 | 20,76 | 4 380 | 228 618 | |
| 2016-11-14 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | -22 805 | 0 | -100,00 | ||||
| 2016-11-14 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -17 805 | 10 803 | -62,24 | 38,54 | -686 205 | 416 348 |
| 2016-11-14 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 17 805 | 28 608 | 164,82 | 11,27 | 200 662 | 322 412 |
| 2016-11-14 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -5 000 | 10 803 | -31,64 | 34,08 | -170 400 | 368 166 |
| 2016-11-14 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 5 000 | 15 803 | 46,28 | 11,27 | 56 350 | 178 100 |
| 2016-11-09 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | -5 000 | 22 805 | -17,98 | ||||
| 2016-11-09 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -5 000 | 10 803 | -31,64 | 34,00 | -170 000 | 367 302 |
| 2016-11-09 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 5 000 | 15 803 | 46,28 | 11,27 | 56 350 | 178 100 |
| 2016-07-01 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
J - Other | 213 | 10 803 | 2,01 | 20,76 | 4 421 | 224 238 | |
| 2016-01-19 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | -522 | 10 590 | -4,70 | 41,46 | -21 640 | 439 021 | |
| 2016-01-19 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | -747 | 9 801 | -7,08 | 41,46 | -30 967 | 406 305 | |
| 2016-01-19 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | -564 | 8 673 | -6,11 | 41,46 | -23 383 | 359 572 | |
| 2016-01-19 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | -277 | 7 822 | -3,42 | 41,46 | -11 484 | 324 284 | |
| 2016-01-19 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | -1 311 | 3 931 | -25,01 | ||||
| 2016-01-19 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | -1 875 | 3 750 | -33,33 | ||||
| 2016-01-19 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | -1 415 | 1 415 | -50,00 | ||||
| 2016-01-19 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | -694 | 0 | -100,00 | ||||
| 2016-01-19 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Restricted Stock Units |
A - Award | 6 373 | 6 373 | |||||
| 2016-01-19 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 1 311 | 11 112 | 13,38 | ||||
| 2016-01-19 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 1 875 | 10 548 | 21,62 | ||||
| 2016-01-19 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 1 415 | 9 237 | 18,09 | ||||
| 2016-01-19 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 694 | 8 099 | 9,37 | ||||
| 2016-01-04 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
A - Award | 38 240 | 38 240 | |||||
| 2016-01-04 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
J - Other | 89 | 7 405 | 1,22 | 47,71 | 4 246 | 353 296 | |
| 2015-12-17 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | -3 909 | 0 | -100,00 | ||||
| 2015-12-17 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -3 909 | 7 316 | -34,82 | 58,85 | -230 045 | 430 547 |
| 2015-12-17 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 3 909 | 11 225 | 53,43 | 14,47 | 56 563 | 162 426 |
| 2015-12-17 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | -4 000 | 3 909 | -50,58 | ||||
| 2015-12-17 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -4 000 | 7 316 | -35,35 | 56,00 | -224 000 | 409 696 |
| 2015-12-17 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 4 000 | 11 316 | 54,67 | 14,47 | 57 880 | 163 743 |
| 2015-11-12 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | -5 000 | 7 909 | -38,73 | ||||
| 2015-11-12 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -5 000 | 7 316 | -40,60 | 64,00 | -320 000 | 468 224 |
| 2015-11-12 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 5 000 | 12 316 | 68,34 | 14,47 | 72 350 | 178 213 |
| 2015-11-09 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | -5 000 | 12 909 | -27,92 | ||||
| 2015-11-09 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -5 000 | 7 316 | -40,60 | 56,00 | -280 000 | 409 696 |
| 2015-11-09 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 5 000 | 12 316 | 68,34 | 14,47 | 72 350 | 178 213 |
| 2015-07-02 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
J - Other | 87 | 7 316 | 1,20 | 48,59 | 4 227 | 355 455 | |
| 2015-03-25 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | -9 000 | 17 909 | -33,45 | ||||
| 2015-03-25 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -9 000 | 7 229 | -55,46 | 71,01 | -639 090 | 513 331 |
| 2015-03-25 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 9 000 | 16 229 | 124,50 | 14,47 | 130 230 | 234 834 |
| 2015-03-25 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | -6 000 | 26 909 | -18,23 | ||||
| 2015-03-25 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -1 000 | 7 229 | -12,15 | 71,00 | -71 000 | 513 259 |
| 2015-03-25 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 1 000 | 8 229 | 13,83 | 14,47 | 14 470 | 119 074 |
| 2015-03-25 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -5 000 | 7 229 | -40,89 | 69,80 | -349 020 | 504 613 |
| 2015-03-25 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 5 000 | 12 229 | 69,17 | 14,47 | 72 350 | 176 954 |
| 2015-01-20 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | -714 | 7 229 | -8,99 | 67,96 | -48 526 | 491 312 | |
| 2015-01-20 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | -539 | 6 068 | -8,16 | 67,96 | -36 633 | 412 406 | |
| 2015-01-20 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | -265 | 5 192 | -4,86 | 67,96 | -18 010 | 352 869 | |
| 2015-01-20 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | -1 875 | 5 625 | -25,00 | ||||
| 2015-01-20 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | -1 415 | 2 830 | -33,33 | ||||
| 2015-01-20 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | -694 | 694 | -50,00 | ||||
| 2015-01-20 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Restricted Stock Units |
A - Award | 5 242 | 5 242 | |||||
| 2015-01-20 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 1 875 | 7 943 | 30,90 | ||||
| 2015-01-20 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 1 415 | 6 607 | 27,25 | ||||
| 2015-01-20 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 694 | 5 457 | 14,57 | ||||
| 2015-01-05 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
A - Award | 31 457 | 31 457 | |||||
| 2015-01-05 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
J - Other | 136 | 4 763 | 2,94 | 30,05 | 4 086 | 143 116 | |
| 2014-08-28 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | -5 000 | 0 | -100,00 | ||||
| 2014-08-28 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -2 000 | 4 627 | -30,18 | 40,55 | -81 100 | 187 625 |
| 2014-08-28 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 2 000 | 6 627 | 43,22 | 15,38 | 30 760 | 101 923 |
| 2014-08-28 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 2 000 | 6 627 | 43,22 | 15,38 | 30 760 | 101 923 |
| 2014-08-28 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -1 000 | 4 627 | -17,77 | 40,53 | -40 530 | 187 532 |
| 2014-08-28 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 1 000 | 5 627 | 21,61 | 15,38 | 15 380 | 86 543 |
| 2014-08-28 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -2 000 | 4 627 | -30,18 | 40,50 | -81 000 | 187 394 |
| 2014-07-01 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
J - Other | 291 | 4 627 | 6,71 | 30,20 | 8 788 | 139 738 | |
| 2014-06-25 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | -11 200 | 5 000 | -69,14 | ||||
| 2014-06-25 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -5 000 | 4 336 | -53,56 | 36,54 | -182 715 | 158 450 |
| 2014-06-25 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 5 000 | 9 336 | 115,31 | 15,38 | 76 900 | 143 588 |
| 2014-06-25 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -6 200 | 4 336 | -58,85 | 36,97 | -229 195 | 160 289 |
| 2014-06-25 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 6 200 | 10 536 | 142,99 | 15,38 | 95 356 | 162 044 |
| 2014-01-17 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | -265 | 4 336 | -5,76 | 47,08 | -12 476 | 204 143 | |
| 2014-01-17 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | -539 | 3 906 | -12,13 | 47,08 | -25 377 | 183 899 | |
| 2014-01-17 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | -695 | 1 388 | -33,37 | ||||
| 2014-01-17 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | -1 415 | 4 245 | -25,00 | ||||
| 2014-01-17 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Restricted Stock Units |
A - Award | 7 500 | 7 500 | |||||
| 2014-01-17 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 695 | 4 601 | 17,79 | ||||
| 2014-01-17 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 1 415 | 4 445 | 46,70 | ||||
| 2014-01-03 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
A - Award | 45 000 | 45 000 | |||||
| 2014-01-03 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
J - Other | 164 | 3 030 | 5,72 | 24,20 | 3 969 | 73 324 | |
| 2013-12-06 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | -10 000 | 16 200 | -38,17 | ||||
| 2013-12-06 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -4 550 | 2 866 | -61,35 | 39,90 | -181 545 | 114 353 |
| 2013-12-06 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 4 550 | 7 416 | 158,76 | 15,38 | 69 979 | 114 058 |
| 2013-12-06 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -3 640 | 2 866 | -55,95 | 39,94 | -145 382 | 114 468 |
| 2013-12-06 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 3 640 | 6 506 | 127,01 | 15,38 | 55 983 | 100 062 |
| 2013-12-06 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -1 810 | 2 866 | -38,71 | 39,92 | -72 255 | 114 411 |
| 2013-12-06 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 1 810 | 4 676 | 63,15 | 15,38 | 27 838 | 71 917 |
| 2013-09-23 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | -10 000 | 26 200 | -27,62 | ||||
| 2013-09-23 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -10 000 | 2 866 | -77,72 | 35,02 | -350 200 | 100 367 |
| 2013-09-23 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 10 000 | 12 866 | 348,92 | 15,38 | 153 800 | 197 879 |
| 2013-09-11 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | -10 000 | 36 200 | -21,65 | ||||
| 2013-09-11 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -10 000 | 2 866 | -77,72 | 30,22 | -302 250 | 86 625 |
| 2013-09-11 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 10 000 | 12 866 | 348,92 | 15,38 | 153 800 | 197 879 |
| 2013-07-03 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
J - Other | 756 | 2 866 | 35,83 | 9,20 | 6 953 | 26 359 | |
| 2013-05-02 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | -6 145 | 0 | -100,00 | ||||
| 2013-05-02 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | -23 800 | 0 | -100,00 | ||||
| 2013-05-02 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -6 145 | 2 110 | -74,44 | 22,26 | -136 794 | 46 971 |
| 2013-05-02 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 6 145 | 8 255 | 291,23 | 11,12 | 68 332 | 91 796 |
| 2013-05-02 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -23 800 | 2 110 | -91,86 | 22,26 | -529 812 | 46 971 |
| 2013-05-02 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 23 800 | 25 910 | 1 127,96 | 6,81 | 162 078 | 176 447 |
| 2013-05-02 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | -30 000 | 6 145 | -83,00 | ||||
| 2013-05-02 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -30 000 | 2 110 | -93,43 | 22,51 | -675 153 | 47 486 |
| 2013-05-02 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 30 000 | 32 110 | 1 421,80 | 11,12 | 333 600 | 357 063 |
| 2013-02-01 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
A - Award | 34 000 | 34 000 | |||||
| 2013-02-01 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Restricted Stock Units |
A - Award | 5 660 | 5 660 | |||||
| 2013-01-17 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | -309 | 2 110 | -12,77 | 14,00 | -4 326 | 29 540 | |
| 2013-01-17 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | -695 | 2 083 | -25,02 | ||||
| 2013-01-17 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 695 | 2 419 | 40,31 | ||||
| 2013-01-03 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
J - Other | 447 | 1 724 | 35,00 | 8,87 | 3 967 | 15 299 | |
| 2012-07-11 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | -5 000 | 23 800 | -17,36 | ||||
| 2012-07-11 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | -5 500 | 0 | -100,00 | ||||
| 2012-07-11 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -5 000 | 1 277 | -79,66 | 13,51 | -67 550 | 17 252 |
| 2012-07-11 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 5 000 | 6 277 | 391,54 | 6,81 | 34 050 | 42 746 |
| 2012-07-11 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -5 500 | 1 277 | -81,16 | 13,51 | -74 305 | 17 252 |
| 2012-07-11 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 5 500 | 6 777 | 430,70 | 6,84 | 37 620 | 46 355 |
| 2012-07-03 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | -6 000 | 5 500 | -52,17 | ||||
| 2012-07-03 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -6 000 | 1 277 | -82,45 | 12,91 | -77 460 | 16 486 |
| 2012-07-03 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 6 000 | 7 277 | 469,85 | 6,84 | 41 040 | 49 775 |
| 2012-07-03 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
J - Other | 648 | 1 277 | 103,02 | 6,13 | 3 971 | 7 826 | |
| 2012-03-07 |
|
4/A | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
A - Award | 25 013 | 25 013 | |||||
| 2012-03-07 |
|
4/A | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
J - Other | 324 | 629 | 106,23 | 6,13 | 1 986 | 3 855 | |
| 2012-01-17 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Restricted Stock Units |
A - Award | 2 778 | 2 778 | |||||
| 2012-01-03 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
A - Award | 25 013 | 25 013 | |||||
| 2012-01-03 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
J - Other | 324 | 629 | 106,23 | 6,13 | 1 986 | 3 855 | |
| 2010-01-05 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
A - Award | 27 805 | 27 805 | |||||
| 2010-01-05 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
J - Other | 195 | 1 171 | 19,98 | 9,44 | 1 841 | 11 058 | |
| 2004-07-02 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
J - Other | 295 | 858 | 52,40 | 4,86 | 1 434 | 4 172 |
